Hormel Foods Refines Portfolio, Completes CytoSport Sale

Hormel Foods Corporation HRL completes the divestiture of CytoSport business to PepsiCo, Inc. PEP. The deal, announced in Feb, 2019, was valued at almost $465 million. Let’s take a closer look.

Is CytoSport Sale a Prudent Move?

As a result of this transaction, renowned brands such as Evolve and Muscle Milk no longer form part of Hormel Foods’ business. We note that management had earlier announced that the performance of CytoSport business was unimpressive during fiscal 2018. Declines in the single serve ready-to-drink product lines and powder products had impaired growth of the category. Intense competition and inadequate distribution were other deterrents. These adversities might have led the company to divest the business. Such efforts are likely to enable the company to focus on other areas with substantial growth potential.

Further, management expects that Pepsi’s strong expertise in the beverages space makes it an appropriate option to include CytoSport business brands. Moreover, Pepsi has been the distribution partner for Muscle Milk for long and holds substantial experience in marketing products in the sports nutrition category. These factors are likely to boost the CytoSport business.

Hormel Foods has not made statements of the divestitures’ material impact on the top line in fiscal 2019.

Wrapping Up

Hormel Foods has undertaken business divestitures in the past as well.  The company sold the Fremont processing facility to WholeStone Farms in December 2018. Tough dynamics in the pork industry have compelled the company to resort to the divestiture. In fact, higher tariffs have weighed on fresh pork export volumes, sales and profits at Hormel Foods’ International division. Such headwinds combined with weakness in the turkey segment are impacting investors’ sentiments, evident from the stock’s 4.7% decline in the past three months, against the industry’s rise of 9.5%.

Nevertheless, this Zacks Rank #3 (Hold) company focuses on making strategic advertisement investments to support growth of brands and launch products that are in line with consumers’ preferences. Moreover, the company resorts to prudent buyouts. To this end, the Columbus and Fontanini buyouts are driving performance in the Refrigerated Foods segment. Also, the Ceratti acquisition is supporting growth in the International segment.

We expect these factors, combined with management’s efforts to refine the portfolio, to cushion the aforementioned hurdles and boost investors’ sentiments in the forthcoming periods.

Looking For Consumer Staples Stocks? Check These

MEDIFAST MED, with long-term earnings growth rate of 20%, sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

General Mills GIS, with a Zacks Rank #2 (Buy), has long-term earnings per share (EPS) growth rate of 7.5%.

Will you retire a millionaire?

One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.

Click to get it free >>

Click to get this free report

Pepsico, Inc. (PEP): Free Stock Analysis Report

Hormel Foods Corporation (HRL): Free Stock Analysis Report

General Mills, Inc. (GIS): Free Stock Analysis Report

MEDIFAST INC (MED): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Technology Videos

    Apple’s Big Year Ahead for New Products

    Between AR/VR headsets, new Macs, and an automobile, Apple Inc. is set to surprise this year with the debut of new products across the board. Bloomberg's Mark Gurman covers the latest tech expected from Apple in this week's episode of “Power Up.”

    Feb 17, 2021


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More